-
Signature
-
/s/ Samantha Lagocki, POA
-
Issuer symbol
-
EQIX
-
Transactions as of
-
02 Dec 2024
-
Transactions value $
-
$-2,851,209
-
Form type
-
4
-
Filing time
-
03 Dec 2024, 18:48:39 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
EQIX |
Common Stock |
Options Exercise |
$0 |
+5,646 |
+1455% |
$0.000000 |
6,034 |
02 Dec 2024 |
Direct |
|
| transaction |
EQIX |
Common Stock |
Sale |
$-1,159,849 |
-1,209 |
-20% |
$959.35 |
4,825 |
03 Dec 2024 |
Direct |
F1, F2 |
| transaction |
EQIX |
Common Stock |
Sale |
$-226,657 |
-236 |
-4.89% |
$960.41 |
4,589 |
03 Dec 2024 |
Direct |
F3 |
| transaction |
EQIX |
Common Stock |
Sale |
$-115,353 |
-120 |
-2.61% |
$961.28 |
4,469 |
03 Dec 2024 |
Direct |
F4 |
| transaction |
EQIX |
Common Stock |
Sale |
$-459,210 |
-477 |
-10.7% |
$962.70 |
3,992 |
03 Dec 2024 |
Direct |
F5 |
| transaction |
EQIX |
Common Stock |
Sale |
$-407,724 |
-423 |
-10.6% |
$963.89 |
3,569 |
03 Dec 2024 |
Direct |
F6 |
| transaction |
EQIX |
Common Stock |
Sale |
$-482,416 |
-500 |
-14% |
$964.83 |
3,069 |
03 Dec 2024 |
Direct |
F7 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
EQIX |
Restricted Stock Unit |
Options Exercise |
$0 |
-5,646 |
-25% |
$0.000000 |
16,935 |
02 Dec 2024 |
Common Stock |
5,646 |
$0.000000 |
Direct |
F8, F9 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: